Sponsor pipeline

Sun Yat-sen University clinical trial pipeline

Get alerts when Sun Yat-sen University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

15 trials changed in the last 30 days: 1 stopped, 3 with notable changes, 11 with minor changes only.

Show 11 trials with minor changes only
  1. Minor

    Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma

    Primary completion pushed from Aug 30, 2027 to Sep 29, 2027

    Also in this update: Study completion pushed from Aug 30, 2029 to Sep 29, 2029; Start date changed from estimate of Aug 30, 2026 to Sep 29, 2026

    Sun Yat-sen UniversityPhase 3 NCT07796789 Registry history of NCT07796789 on ClinicalTrials.gov (opens the registry)

  2. Minor
    4 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-19 NCT07880548 Remimazolam vs Propofol for Long-Term Sedation in Mechanically Ventilated ICU Patients Phase 3 Not Yet Recruiting
2026-10-16 NCT07879417 Phase II Trial of Hypofractionated Radiotherapy Guided by Optical Surface Imaging and… Phase 2 Not Yet Recruiting
2026-10-14 NCT07874308 HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World… Recruiting
2026-10-14 NCT07874464 Prospective Phase II Study of Concurrent Radiotherapy Combined With Full-Course… Phase 2 Not Yet Recruiting
2026-10-13 NCT07870772 Lenvatinib Plus Bevacizumab and PD-1 Inhibition Versus Bevacizumab Plus PD-1 Inhibition… Phase 2 Not Yet Recruiting
2026-10-07 NCT07863141 A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After… Phase 2 Recruiting
2026-09-29 NCT07847359 Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab… Phase 2 Recruiting

Active trials by phase

Early Phase 1
2
Phase 1
12
Phase 1/2
20
Phase 2
238
Phase 2/3
12
Phase 3
102
Phase 4
3
Not charted: 164 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 43

Get alerts when Sun Yat-sen University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free